SCHEDULE 13D
This Amendment No. 9 (Amendment No. 9) amends and supplements the Schedule 13D filed with the Securities and Exchange Commission (the
SEC) on June 1, 2022 (the Initial Schedule 13D and together with Amendment No. 1 thereto filed with the SEC on October 31, 2022 (Amendment No. 1), Amendment No. 2 thereto filed with the
SEC on December 5, 2022 (Amendment No. 2), Amendment No. 3 thereto filed with the SEC on December 19, 2022 (Amendment No. 3), Amendment No. 4 thereto filed with the SEC on January 23, 2023
(Amendment No. 4), Amendment No. 5 thereto filed with the SEC on February 13, 2023 (Amendment No. 5), Amendment No. 6 thereto filed with the SEC on March 3, 2023 (Amendment
No. 6), Amendment No. 7 thereto filed with the SEC on May 1, 2023 (Amendment No. 7), and Amendment No. 8 thereto filed with the SEC on May 17, 2023 (Amendment No. 8) the Schedule
13D) by CBI USA, Inc. with respect to the Common Stock, par value $0.0001 per share, of Exicure, Inc. (Exicure or the Company).
This Amendment No. 9 is being filed jointly by CBI USA, Inc. (CBI USA) and DGP Co., Ltd. (DGP) as a result of the transactions
described herein and amends Items 2, 3, 4, 5, 6 and 7 to the extent set forth below. In this Amendment No. 9, CBI USA and DGP are each a Reporting Person and, collectively, the Reporting Persons. In the Initial Schedule
13D and all prior amendments, Reporting Person refers to CBI USA. Capitalized terms used herein and not otherwise defined in this Amendment No. 9 shall have the meanings set forth in the Schedule 13D.
Item 2. Identity and Background
Item 2 is amended
and restated in its entirety to read as follows:
This Schedule 13D is being filed jointly by CBI USA, a Delaware corporation, and DGP, a Republic of
Korea listed company.
The address of CBI USA is c/o Baker & Hostetler LLP, One North Wacker Drive, Suite 4500, Chicago, IL 60606-2841. The
principal business of CBI USA is investing in dynamic businesses initially in the life sciences.
CBI USA is a subsidiary of CBI Co. Ltd., a Republic of
Korea listed company (CBI Co). The address of CBI Co is 208, namdong-daero, namdong-gu, Incheon, Republic of Korea (21643). The principal business of the CBI Co is a manufacturer of automotive
engine and mission parts.
The address of DGP is 23, Geurintekeu-ro,
Yeonggwang-eup, Yeonggwang-gun, Jeollanam-do, Republic of Korea (57024). The principal business of DGP is producing and selling
electricity using wind and solar power among new and renewable energies.
The name, business address, principal occupation and citizenship of
(1) each executive officer and director of each of the Reporting Persons and (2) each executive officer and director of CBI Co are set forth on Schedule 1 hereto.